Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Biology Systems, Velocidy Bio Ink Distribution Deal

NEW YORK – Molecular Biology Systems, a pioneer of two-minute PCR, announced Wednesday that Velocidy Bio will distribute MBS' NextGenPCR instruments, accessories, and consumables in the US and Canada.

The Goes, Netherlands-based firm's NextGenPCR instrument enables two-minute, 30-cycle amplification. Consumables include 96- and 384-well sealed microplates and proprietary foil-piercing pipette tips to recover PCR products.

The NextGenPCR system accelerates the PCR protocol by using proprietary spatial thermal cycling. It has been adopted across laboratory segments, including public and private research and testing labs in academia, government, biotech, and pharmaceutical labs, MBS said in a statement, with an increasing rate of placements since launching two years ago.

Velocidy Bio is focused on accelerating laboratory protocols, with an initial emphasis on reducing the time required to extract, amplify, and analyze nucleic acids. 

"We look forward to working with Velocidy Bio, an innovative distributor focused on improving the laboratory experience by accelerating protocols," said MBS CEO Gert de Vos.

Financial and other terms of the deal were not disclosed.

The NextGenPCR system is already distributed in Germany and other countries globally. It was previously distributed in the US by Canon Biomedical, Canon USA's life sciences subsidiary, until that firm ceased operations in January of last year.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.